Mammalian Expression Vectors

2021 ◽  
pp. 523-549
Author(s):  
Ricky R. Hirschhorn ◽  
Nava Sarver
Keyword(s):  
Expression Vectors ◽  
Mammalian Expression

Use of a general purpose mammalian expression vector for studying intracellular protein targeting: identification of critical residues in the nuclear lamin A/C nuclear localization signal

1993 ◽  
Vol 105 (2) ◽  
pp. 481-488 ◽  
Author(s):  
J.V. Frangioni ◽  
B.G. Neel
Keyword(s):  
Amino Acid ◽  
Nuclear Localization ◽  
Nuclear Localization Signal ◽  
Protein Targeting ◽  
General Purpose ◽  
Expression Vectors ◽  
Intracellular Protein ◽  
Mammalian Expression ◽  
Nuclear Lamin ◽  
Localization Signal

We have constructed a general purpose mammalian expression vector for the study of intracellular protein targeting. The vector, p3PK, facilitates construction of N- and/or C-terminal fusions of an amino acid sequence of interest to the normally cytosolic protein chicken muscle pyruvate kinase (CMPK). The vector has been engineered such that any fusion construct can be subcloned into the versatile pJx omega family of mammalian expression vectors and into pGEX bacterial expression vectors, for the generation of affinity reagents. In this paper, we demonstrate the general utility of p3PK by redirecting CMPK to mitochondria (using the twelve amino acid pre-sequence of yeast cytochrome c oxidase subunit IV) and to the nucleus (using a putative eight amino acid nuclear localization signal from human nuclear lamins A and C). We also report that, contrary to the predictions of previously published work, substitution of a critical residue in the nuclear lamin A/C nuclear localization signal (the equivalent of lysine 128 in the SV40 large T nuclear localization signal) retains nuclear localization, and discuss how amino acid context might affect targeting to the nucleus.

Mammalian Expression Vectors

Vectors ◽  
1988 ◽  
pp. 467-492
Author(s):  
Anthony A.G. Ridgway
Keyword(s):  
Expression Vectors ◽  
Mammalian Expression

scholarly journals Effect of single amino acid substitutions on the formation of the PlA and Bak alloantigenic epitopes

Blood ◽  
1991 ◽  
Vol 78 (3) ◽  
pp. 681-687 ◽  
Author(s):  
A Goldberger ◽  
M Kolodziej ◽  
M Poncz ◽  
JS Bennett ◽  
PJ Newman
Keyword(s):  
Amino Acid ◽  
Expression System ◽  
Single Amino Acid ◽  
Expression Vectors ◽  
Membrane Glycoproteins ◽  
Amino Acid Polymorphism ◽  
Specific Expression ◽  
Mammalian Expression ◽  
Single Amino Acid Polymorphisms ◽  
Necessary And Sufficient

Abstract The subunits that comprise the platelet-specific integrin alpha IIb beta 3 are polymorphic in nature, with several allelic forms present in the human gene pool. Minor changes in the secondary and tertiary structures of platelet membrane glycoproteins (GP) IIb and IIIa encoded by these alleles can result in an alloimmune reaction after transfusion or during pregnancy. To better understand the molecular structure of the PlA alloantigen system, located on GPIIIa, and the Bak alloantigen on GPIIb, we used a heterologous mammalian expression system to express these integrin subunits in their known polymorphic forms. An expression vector containing the PlA1 form of a GPIIIa cDNA, which encodes a leucine at amino acid 33 (Leu33), was modified to express the PlA2- associated form encoding a proline at amino acid 33 (Pro33). Similarly, a Baka GPIIb cDNA expressing an isoleucine at amino acid 843 (IIe843) was modified to express the Bakb form containing a serine at the same position (Ser843). Transfection of these vectors into COS cells resulted in the synthesis of GPIIb and GPIIIa molecules that were identical in size to those present in platelet lysates. Immunoprecipitation of the GPIIIa-transfected COS lysates with PlA)- specific alloantisera indicated that the Leu33 form was recognized only by anti-PIA1 sera while the Pro33 form was bound only by anti-PlA2 sera, showing that single amino acid polymorphisms are necessary and sufficient to direct the formation of the PlA1 and PlA2 alloepitopes. Similar experiments with Bak allele-specific expression vectors indicated that while the amino acid polymorphism (IIe843 in equilibrium Ser843) was necessary, posttranslational processing of pro-IIb was required for efficient exposure of both the Baka and Bakb alloepitopes.

DEVELOPMENT OF VERSATILE MAMMALIAN EXPRESSION VECTORS THAT RESPOND TO HYPOXIA

2004 ◽  
Vol 13 (3) ◽  
pp. 128
Author(s):  
Jae-Young Lee ◽  
Jonghoe Byun ◽  
Young-Sam Lee ◽  
Koung Li Kim ◽  
Hyung-Suk Jang ◽  
...  
Keyword(s):  
Expression Vectors ◽  
Mammalian Expression

scholarly journals 11 Study of Polynucleotide Kinase/Phosphatase (PNKP) Mutations Found in a Patient with Microcephaly, Seizures, and Developmental Delay (MCSZ) and Glioblastoma

2018 ◽  
Vol 45 (S3) ◽  
pp. S2-S2
Author(s):  
Bingcheng Jiang ◽  
Chibawanye I. Ene ◽  
Bonnie Cole ◽  
Jeff Ojemann ◽  
Sarah Leary ◽  
...  
Keyword(s):  
Human Cancer ◽  
Neurodevelopmental Disorder ◽  
Site Directed Mutagenesis ◽  
Expression Vectors ◽  
Wild Type ◽  
Double Mutation ◽  
Mutant Proteins ◽  
Human Cancer Cell Lines ◽  
Mammalian Expression ◽  
Polynucleotide Kinase

The enzyme polynucleotide kinase/phosphatase (PNKP) plays a key role in DNA repair by resolving the chemistry at DNA strand breaks. Mutations in PNKP (chromosome 19q13.4) are known to cause MCSZ, a serious neurodevelopmental disorder, but to date there has been no link to cancer initiation or progression. However, a child with MCSZ recently presented at Seattle Children's Hospital with a 3-cm glioblastoma. The child was shown to have two germline mutations in PNKP. To study the effects of the PNKP mutations found in this patient, we generated mutant PNKP cDNAs carrying either the individual mutations or the double mutation using site directed mutagenesis. These cDNAs were incorporated into bacterial and mammalian expression vectors. The bacterially expressed mutant proteins as well as the wild type have been purified and are undergoing testing for PNKP DNA kinase and phosphatase activity. The PNKP cDNAs, fused to GFP, were expressed in Hela and HCT116 human cancer cell lines. High-content analysis and micro-irradiation techniques are being used to determine PNKP localization within the cells and recruitment to damaged DNA. Our preliminary results indicate that the mutations alter the ratio of nuclear to cytoplasmic PNKP compared to the wild-type protein.

scholarly journals Firefly luciferase gene: structure and expression in mammalian cells.

1987 ◽  
Vol 7 (2) ◽  
pp. 725-737 ◽  
Author(s):  
J R de Wet ◽  
K V Wood ◽  
M DeLuca ◽  
D R Helinski ◽  
S Subramani
Keyword(s):  
Mammalian Cells ◽  
Firefly Luciferase ◽  
Full Length ◽  
Expression Vectors ◽  
Luciferase Expression ◽  
Luciferase Gene ◽  
S1 Nuclease ◽  
Reading Frame ◽  
Mammalian Expression ◽  
Firefly Luciferase Gene

The nucleotide sequence of the luciferase gene from the firefly Photinus pyralis was determined from the analysis of cDNA and genomic clones. The gene contains six introns, all less than 60 bases in length. The 5' end of the luciferase mRNA was determined by both S1 nuclease analysis and primer extension. Although the luciferase cDNA clone lacked the six N-terminal codons of the open reading frame, we were able to reconstruct the equivalent of a full-length cDNA using the genomic clone as a source of the missing 5' sequence. The full-length, intronless luciferase gene was inserted into mammalian expression vectors and introduced into monkey (CV-1) cells in which enzymatically active firefly luciferase was transiently expressed. In addition, cell lines stably expressing firefly luciferase were isolated. Deleting a portion of the 5'-untranslated region of the luciferase gene removed an upstream initiation (AUG) codon and resulted in a twofold increase in the level of luciferase expression. The ability of the full-length luciferase gene to activate cryptic or enhancerless promoters was also greatly reduced or eliminated by this 5' deletion. Assaying the expression of luciferase provides a rapid and inexpensive method for monitoring promoter activity. Depending on the instrumentation employed to detect luciferase activity, we estimate this assay to be from 30- to 1,000-fold more sensitive than assaying chloramphenicol acetyltransferase expression.

New mammalian expression vectors

Nature ◽  
1990 ◽  
Vol 348 (6296) ◽  
pp. 91-92 ◽  
Author(s):  
B. Moss ◽  
O. Elroy-Stein ◽  
T. Mizukami ◽  
W. A. Alexander ◽  
T. R. Fuerst
Keyword(s):  
Expression Vectors ◽  
Mammalian Expression

scholarly journals Intracellular Expression of the Plasmid-Encoded Toxin from Enteroaggregative Escherichia coli

2003 ◽  
Vol 71 (9) ◽  
pp. 5364-5370 ◽  
Author(s):  
Bao Quan Sui ◽  
Pinaki R. Dutta ◽  
James P. Nataro
Keyword(s):  
Escherichia Coli ◽  
Cell Elongation ◽  
Morphological Changes ◽  
Intracellular Localization ◽  
Toxic Effects ◽  
Expression Vectors ◽  
Passenger Domain ◽  
Mammalian Expression ◽  
Site Of Action ◽  
Intracellular Expression

ABSTRACT The plasmid-encoded toxin (Pet) from enteroaggregative Escherichia coli is a serine protease autotransporter that acts as an enterotoxin and cytotoxin. When applied to epithelial cells in culture, purified toxin induces cell elongation and rounding, followed by exfoliation of cells from the substratum. These effects are accompanied by loss of actin stress fibers and electrophysiologic changes. Although it has been hypothesized that Pet has an intracellular site of action, evidence for this is indirect. In addition, Pet has recently been shown to cleave spectrin in vitro and in vivo. If Pet requires intracellular localization to execute its toxic effects, then intracellular expression of the protein could induce cytopathic effects similar to those observed when the toxin is applied to the cell surface. To test this hypothesis, we expressed the mature Pet toxin (comprising only the passenger domain of the Pet precursor) in the cytoplasm of HEp-2 cells by using mammalian expression vectors. Separately, we expressed the Pet passenger domain mutated at the catalytic serine (PetS260A), a construct that has been reported to lack toxic effects. Forty-eight hours after transient transfection of pcDNA3.1-pet in HEp-2 cells, we observed cell elongation and other morphological changes similar to those induced by applied toxin. Cells transfected with pcDNA3.1 vector alone appeared normal, while cells expressing the PetS260A mutant displayed similar (though less pronounced) changes compared with those in cells expressing pcDNA3.1-pet. Notably, intracellular expression of Pet was accompanied by condensation of the spectrin cytoskeleton. These studies corroborate an intracellular site of action for the Pet toxin, further implicate a role for spectrin in Pet intoxication, and provide a powerful tool for Pet structure and function analyses.

Sign in / Sign up

Export Citation Format

Share Document